Header Logo

Connection

AMANDA GRIMES to Child

Back to Details
This is a "connection" page, showing publications AMANDA GRIMES has written about Child.
AMANDA GRIMES
Connection Strength
0.497
Child
  1. Predictors of response to emergent therapies in paediatric immune thrombocytopenia. Br J Haematol. 2025 Nov; 207(5):2091-2098.
    View in: PubMed
    Score: 0.054
  2. Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Adv. 2024 11 12; 8(21):5529-5538.
    View in: PubMed
    Score: 0.051
  3. Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia. Blood Adv. 2024 10 08; 8(19):5118-5121.
    View in: PubMed
    Score: 0.051
  4. Refractory autoimmune cytopenias in pediatric Evans syndrome with underlying systemic immune dysregulation. Eur J Haematol. 2021 Jun; 106(6):783-787.
    View in: PubMed
    Score: 0.040
  5. 50 Years Ago in The Journal of Pediatrics: Thiamine-Responsive Megaloblastic Anemia. J Pediatr. 2019 04; 207:53.
    View in: PubMed
    Score: 0.035
  6. Pediatric ITP: is it different from adult ITP? Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):405-411.
    View in: PubMed
    Score: 0.034
  7. Predicting development of pediatric chronic immune thrombocytopenia at disease onset using a statistical risk model. Blood. 2026 Apr 16; 147(16):1863-1872.
    View in: PubMed
    Score: 0.014
  8. The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia. Res Pract Thromb Haemost. 2026 Mar; 10(3):103417.
    View in: PubMed
    Score: 0.014
  9. Pediatric Evans Syndrome Diagnostic Evaluation Patterns: Survey Results From the Pediatric ITP Consortium of North America. Pediatr Blood Cancer. 2026 Apr; 73(4):e70121.
    View in: PubMed
    Score: 0.014
  10. Results From the 2024 United States Report Card on Physical Activity for Children and Youth. J Phys Act Health. 2026 Mar 01; 23(3):293-300.
    View in: PubMed
    Score: 0.014
  11. Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial. JAMA. 2025 11 25; 334(20):1816-1826.
    View in: PubMed
    Score: 0.014
  12. Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. Pediatr Blood Cancer. 2026 01; 73(1):e32143.
    View in: PubMed
    Score: 0.014
  13. What is in a name: defining pediatric refractory ITP. Blood Adv. 2024 10 08; 8(19):5112-5117.
    View in: PubMed
    Score: 0.013
  14. Pediatric autoimmune myelofibrosis: Experience from a large pediatric tertiary care center. Pediatr Blood Cancer. 2023 04; 70(4):e30144.
    View in: PubMed
    Score: 0.011
  15. Pediatric Eosinophilia: A Review and Multiyear Investigation into Etiologies. J Pediatr. 2023 02; 253:232-237.e1.
    View in: PubMed
    Score: 0.011
  16. Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on antiretroviral therapy. AIDS. 2023 03 01; 37(3):413-421.
    View in: PubMed
    Score: 0.011
  17. Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy. AIDS. 2022 12 01; 36(15):2139-2146.
    View in: PubMed
    Score: 0.011
  18. Molecular Diagnosis Is Vital to the Accurate Classification and Management of Thrombotic Thrombocytopenic Purpura in Children. Front Immunol. 2022; 13:836960.
    View in: PubMed
    Score: 0.011
  19. Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series. Pediatr Hematol Oncol. 2021 Oct; 38(7):663-668.
    View in: PubMed
    Score: 0.010
  20. Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences. Blood. 2020 07 30; 136(5):640-643.
    View in: PubMed
    Score: 0.010
  21. Fatigue in children and adolescents with immune thrombocytopenia. Br J Haematol. 2020 10; 191(1):98-106.
    View in: PubMed
    Score: 0.009
  22. Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review. Am J Hematol. 2019 04; 94(4):461-466.
    View in: PubMed
    Score: 0.009
  23. Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia. J Pediatr Hematol Oncol. 2018 10; 40(7):e415-e420.
    View in: PubMed
    Score: 0.008
  24. Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.008
  25. Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget. 2017 Jul 11; 8(28):46065-46070.
    View in: PubMed
    Score: 0.008
  26. Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.007
  27. Hydroxyurea: a new old therapy for Langerhans cell histiocytosis. Blood. 2016 11 17; 128(20):2462-2465.
    View in: PubMed
    Score: 0.007
  28. Attitudes of Arkansas' primary care physicians toward the HPV vaccine. J Ark Med Soc. 2009 Nov; 106(5):113-7.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.